Professional
Added to YB: 2025-04-11
Pitch date: 2025-04-08
ICLR [neutral]
ICON Public Limited Company
+32.25%
current return
Author Info
No bio for this author
Company Info
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
Market Cap
$12.6B
Pitch Price
$141.08
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.01
P/E
22.02
EV/Sales
1.93
Sector
Life Sciences Tools and Services
Category
growth
GreensKeeper Value Fund Portfolio Holding: ICON Public Limited Company
ICLR (holding update): Leading CRO managing global clinical trials for pharma/biotech. New FDA/CDC personnel creating uncertainty, but drug development continues. ICLR well-positioned to capture market share in clinical trials once regulatory environment stabilizes. Long-term growth potential in essential industry.
Read full article (1 min)